Part I: Chemical Development in the Pharmaceutical Industry.
Why Smoking Cessation Should Be a Priority in HIV Care Today… Alvaro Carrascal, MD, MPH Office of the Medical Director AIDS Institute AI is a Local Performance.
Introduction to HIV Discordant Couple Insemination Deborah J. Anderson, Ph.D. Dept Medicine and Center for AIDS Research Harvard Medical School and Department.
1 Monitoring and Evaluation: HIV/AIDS Programs. 2 Learning Objectives At the end of this session, participants will be able to: Identify M&E implications.
Slide #1 CL Thio, MD. Presented at RWCA Clinical Update, August 2006. Optimizing Hepatitis B Virus Treatment in HIV-Infected Individuals Chloe L. Thio,
AIDS CARE GROUP GRACE PAIK, CRNP REGINA UBALDI-ROSEN, CRNP ELLAH NOTA, CRNP GUIDANCE FOR HCV/HIV CO-INFECTION PROGRAMS.
Africans and HIV in the UK: an epidemiological perspective Nov 2006 Tim Chadborn On behalf of the HIV Reporting Section with special thanks to Julia Abernethy.
John Scott, MD, MSc Infectious Diseases Fellows Course July 7, 2011.
Www.aids2014.org State of the Art: Epidemiology and Access Salim S. Abdool Karim Director: CAPRISA Chair: UNAIDS Scientific Expert Panel Pro Vice-Chancellor.
Prevention of mother to child transmission of viral hepatitis Dr. Lawrence Mbuagbaw MD, MPH, PhD, FRSPH 2nd International HIV/Viral Hepatitis Co-infection.
The Immune Suppressed Traveller
2014 “Towards an HIV Cure” symposium Melbourne
